Physician profile
Emily Chan
NPI 1649623414
$1,261.93
in general payments reported to CMS, 2019-2025
16 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $68.47 · 2021: $79.13 · 2023: $117 · 2024: $378 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.59 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $275.65 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $228.78 | 2020-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $161.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $102.14 | 2020-2025 | Gardasil 9, Capvaxive, Gardasil |
| Sanofi-Aventis U.S. LLC | $99.95 | 2019 | |
| Lilly USA, LLC | $79.60 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $67.21 | 2024-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $45.41 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $40.42 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $37.72 | 2023-2024 | Rexulti |
| Glaxosmithkline, LLC. | $34.70 | 2024-2025 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.47 | 2023 | Jardiance |
| Boston Scientific Corporation | $20.04 | 2024 | Watchman Access System |
| Dynavax Technologies Corporation | $18.70 | 2023 | Heplisav-B |
| Janssen Pharmaceuticals, INC | $14.65 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.41 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.